Susanne Arnold, MD
Enriched profileProfessor of Medicine, Markey Cancer Center · University of Kentucky
Susanne Arnold is Professor of Medicine, Markey Cancer Center at University of Kentucky. OpenAlex indexes 404 publications with 6,730 citations (h-index 41); ClinicalTrials.gov lists 31 registered studies with this person as an investigator.
Data verified 23 Oct 2026
Overview
Updated 23 Oct 2026
Susanne Arnold, MD, is Professor of Medicine, Markey Cancer Center at University of Kentucky (Markey Cancer Center). The public record shows 404 publications with 6,730 citations (h-index 41), centered on Lung Cancer Research Studies, Genetic Associations and Epidemiology, Lung Cancer Treatments and Mutations. It also documents an investigator role on 31 registered clinical trials, industry payments reported by 1 companies, 2 NIH-funded awards (2004–2026).
- Top research focus: Lung Cancer Research Studies
- 31 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 23 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 27 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 111.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 23 Oct 2026
Listed as an investigator on 31 registered studies on ClinicalTrials.gov. The most recent:
- Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma
Sponsor: National Cancer Institute (NCI)
Industry payments
Updated 23 Oct 2026
1 company reported payments to CMS in program years 2025–2025. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
44.3%Opioid Agonist18.1%Oxycodone Hcl84%Fentanyl16%Part D≥64 patientsBenzodiazepine9%Alprazolam75%Lorazepam14%Clonazepam11%Part D<11 patients+ 5 more classes in this area
Metabolism & gastrointestinal
19%Serotonin-3 Receptor Antagonist9.9%Ondansetron Hcl60%Ondansetron Odt40%Part D≥49 patientsCorticosteroid3.9%Prednisone100%Part D≥24 patients+ 4 more classes in this area
Hormonal (systemic)
17.4%l-Thyroxine17.4%Levothyroxine Sodium100%Part D≥87 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 23 Oct 2026
2 NIH research awards on record, funded 2004–2026 per NIH RePORTER. The latest:
- The Ohio State University as a Lead Academic Organization (LAO) for the Experimental Therapeutics Clinical Trials Network
Ohio State University
FY2026$1,697,412UM1CA186712
Congress activity
Updated 23 Oct 2026
91 congress contributions (2004–2026) across AACR, ASCO, ASTRO, ESMO per OpenAlex. The most recent:
- Abstract 7305: Evaluating the unfolded protein response as a therapeutic target in clear cell renal cell carcinoma patients
AACR Annual Meeting
AACR2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Most-cited works
by citation count (OpenAlex)Network
Updated 23 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 23 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/susanne-arnold-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
ukhealthcare.uky.edu/wellness-community/blog/meet-oncologist-susanne-arnold-second-generation-doctor-proud-kentuckian
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ukhealthcare.uky.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 23 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Medical degree
University of Kentucky College of Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ukhealthcare.uky.edu ↗
Editorial & leadership roles
journal and society appointments- Member
Lung Cancer Committee, Southwest Oncology Group (SWOG)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cme.cecentral.com ↗ - Member
Early Therapeutics Committee, Southwest Oncology Group (SWOG)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cme.cecentral.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.uky.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cme.cecentral.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cme.cecentral.com ↗
Secondary affiliations
appointments beyond the home institution- Buck-Kentucky Lung Cancer Research Chair
University of Kentucky
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ukhealthcare.uky.edu ↗ - Professor in Medical Oncology and Radiation Medicine (joint appointment)
University of Kentucky
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cme.cecentral.com ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →eurekalert.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Kenneth Ain, MD
University of Kentucky
Zhonglin Hao, MD, PhD
University of Kentucky
David Mannino, MD
University of Kentucky
David Moliterno, MD
University of Kentucky
Pasi Janne, MD, PhD
Dana-Farber Cancer Institute
Julie Brahmer, MD
Johns Hopkins University School of Medicine
Enriqueta Felip, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Funda Meric-Bernstam, MD
The University of Texas MD Anderson Cancer Center